Not first-line antihypertensive agents, but still effective-The efficacy and safety of imidazoline receptor agonists A network meta-analysis /
Cardiovascular disorders are the leading cause of death in the world. Many organ diseases (kidney, heart, and brain) are substantially more prone to develop in people with hypertension. In the treatment of hypertension, first-line medications are recommended, while imidazoline receptor agonists are...
Elmentve itt :
Szerzők: |
Érszegi András Viola Réka Bahar Muhammad Akbar Tóth Barbara Fejes Imola Vágvölgyi Anna Csupor Dezső |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2024
|
Sorozat: | PHARMACOLOGY RESEARCH AND PERSPECTIVES
12 No. 3 |
Tárgyszavak: | |
doi: | 10.1002/prp2.1215 |
mtmt: | 34889255 |
Online Access: | http://publicatio.bibl.u-szeged.hu/33447 |
Hasonló tételek
-
The application of antihypertensive and antiarrhythmic agents practical simulations /
Szerző: Baczkó István, et al. -
The Safety and Efficacy of Citrus aurantium (Bitter Orange) Extracts and p-Synephrine A Systematic Review and Meta-Analysis /
Szerző: Koncz Dorottya, et al.
Megjelent: (2022) -
The Antihypertensive Efficacy of the Triple Fixed Combination of Perindopril, Indapamide, and Amlodipine The Results of the PETRA Study /
Szerző: Ábrahám György, et al.
Megjelent: (2017) -
α2-adrenergic receptors and imidazoline binding sites in the human placenta
Szerző: Bagaméry Krisztina
Megjelent: (1998) -
Levosimendan Efficacy and Safety 20 Years of SIMDAX in Clinical Use /
Szerző: Papp Zoltán, et al.
Megjelent: (2020)